Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
First Trust Capital Strength ETF (FTCS)
Investment Objective/Strategy - The First Trust Capital Strength ETF seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called The Capital Strength IndexSM.
There can be no assurance that the Fund's investment objectives will be achieved.
  • From the stocks in the NASDAQ US Benchmark Index, the largest 500 companies with a minimum three-month average daily dollar trading volume of $5 million are selected.
  • To be eligible for inclusion in the index, companies must have:
    • at least $1 billion in cash or short term investments.
    • a long term debt to market cap ratio less than 30%.
    • a return on equity greater than 15%.
  • Eligible companies are then ranked by a combined short-term (90 days) and long-term (260 days) realized volatility.
  • The 50 companies with the lowest combined volatility score are selected for inclusion in the index.
  • A maximum weight of 30% in any one Industry Classification Benchmark industry is allowed. If an industry has a weight greater than 30%, the highest ranking security by volatility will be removed and replaced with the next eligible security from a different industry. This process is repeated until no industry has a weight greater than 30%.
  • The index stocks are equally weighted initially and on each rebalancing effective date. The index is reconstituted and rebalanced on a quarterly basis.
Fund Overview
Fund TypeLarge Cap Core
Investment AdvisorFirst Trust Advisors L.P.
Investor Servicing AgentBank of New York Mellon Corp
Fiscal Year-End12/31
Inception Price$20.00
Inception NAV$20.00
Rebalance FrequencyQuarterly
Gross Expense Ratio*0.56%
Net Expense Ratio*0.56%
* As of 5/3/2021
Expenses are capped contractually at 0.65% per year, at least until April 30, 2022.
Current Fund Data (as of 1/21/2022)
Closing NAV1$77.97
Closing Market Price2$77.97
Bid/Ask Midpoint$77.95
Bid/Ask Discount0.03%
30-Day Median Bid/Ask Spread30.04%
Total Net Assets$8,884,999,438
Outstanding Shares113,950,002
Daily Volume594,544
Average 30-Day Daily Volume498,320
Closing Market Price 52-Week High/Low$84.75 / $65.61
Closing NAV 52-Week High/Low$84.72 / $65.61
Number of Holdings (excluding cash)50
Top Holdings (as of 1/21/2022)*
Holding Percent
Abbott Laboratories 2.02%
Ball Corporation 2.02%
General Mills, Inc. 2.02%
Gilead Sciences, Inc. 2.02%
The Progressive Corporation 2.02%
Amgen Inc. 2.01%
Automatic Data Processing, Inc. 2.01%
Colgate-Palmolive Company 2.01%
Fidelity National Financial, Inc. 2.01%
Illinois Tool Works Inc. 2.01%

* Excluding cash.  Holdings are subject to change.

NAV History (Since Inception)
Past performance is not indicative of future results.
Distribution Information
Dividend per Share Amt (as of 1/23/2022)4$0.2821
30-Day SEC Yield (as of 12/31/2021)50.89%
Unsubsidized 30-Day SEC Yield (as of 12/31/2021)60.89%
12-Month Distribution Rate (as of 12/31/2021)71.06%
Index Yield (as of 12/31/2021)81.52%
Fund Characteristics (as of 12/31/2021)10
Maximum Market Cap.$2,525,084
Median Market Cap.$99,449
Minimum Market Cap.$16,867
Price/Cash Flow20.02
Bid/Ask Premium/Discount (as of 1/21/2022)
  2021 Q1 2022 Q2 2022 Q3 2022
Days Traded at Premium 186 11 --- ---
Days Traded at Discount 66 3 --- ---
Top Sector Exposure (as of 1/21/2022)
Industrials 29.99%
Health Care 18.04%
Financials 17.99%
Consumer Staples 16.04%
Consumer Discretionary 5.99%
Technology 5.95%
Basic Materials 2.00%
Real Estate 2.00%
Telecommunications 2.00%
Hypothetical Growth of $10,000 Since Inception (as of 1/20/2022) *